<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Candida parapsilosis - UTI PathoDB</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
</head>
<body class="bg-gray-50 text-gray-900">

    <header class="bg-pink-600 text-white p-4 shadow-md">
        <h1 class="text-2xl font-bold text-center">Candida parapsilosis - UTI PathoDB</h1>
    </header>

    <main class="p-6 space-y-6 max-w-4xl mx-auto">

        <!-- Overview -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Overview</h2>
            <p>
                <strong>Candida parapsilosis</strong> is a yeast species commonly associated with human infections, particularly in hospitalized patients. It is an emerging pathogen in urinary tract infections (UTIs), especially in neonates and immunocompromised individuals.
            </p>
        </section>

        <!-- Characteristics -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Characteristics</h2>
            <ul class="list-disc list-inside space-y-1">
                <li>Unicellular yeast</li>
                <li>Forms pseudohyphae and rarely true hyphae</li>
                <li>Part of normal human skin flora</li>
                <li>Efficient biofilm producer, especially on prosthetic materials and catheters</li>
            </ul>
        </section>

        <!-- Pathogenicity -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Pathogenicity</h2>
            <p>
                Candida parapsilosis can adhere to indwelling devices such as catheters and form biofilms, leading to bloodstream and urinary infections. Its ability to thrive on parenteral nutrition solutions enhances its pathogenic potential in clinical settings.
            </p>
        </section>

        <!-- Clinical Significance -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Clinical Significance</h2>
            <p>
                C. parapsilosis is a notable cause of catheter-associated UTIs and bloodstream infections, particularly in neonates and patients in intensive care units. It exhibits reduced susceptibility to echinocandins compared to other Candida species.
            </p>
        </section>

        <!-- Treatment -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Treatment</h2>
            <p>
                Treatment typically includes azoles like fluconazole or amphotericin B. Echinocandins may be less effective, so antifungal susceptibility testing is advised before initiating therapy. Removal of contaminated devices is also essential for successful management.
            </p>
        </section>

        <!-- References -->
        <section>
            <h2 class="text-xl font-semibold mb-2">References</h2>
            <ul class="list-decimal list-inside space-y-1">
                <li>Tavanti A, et al. "Candida parapsilosis complex: Epidemiology and antifungal susceptibility." Future Microbiol. 2010.</li>
                <li>Pappas PG, et al. "Clinical practice guidelines for the management of candidiasis." Clin Infect Dis. 2016.</li>
            </ul>
        </section>

        <!-- Back to Home Link -->
        <div class="mt-6">
            <a href="index.html" class="text-pink-600 hover:underline">&larr; Back to Home</a>
        </div>

    </main>

    <footer class="bg-gray-200 text-center p-4 mt-6">
        &copy; 2025 UTI PathoDB. All rights reserved.
    </footer>

</body>
</html>
